Home
>
National Drug Code (NDC)
>
Caffeine and Sodium Benzoate
Caffeine and Sodium Benzoate - 0517-2502-10 - (Caffeine and Sodium Benzoate)
Drug Information of Caffeine and Sodium Benzoate
| Product NDC: | 0517-2502 |
| Proprietary Name: | Caffeine and Sodium Benzoate |
| Non Proprietary Name: | Caffeine and Sodium Benzoate |
| Active Ingredient(s): | 125 mg/mL & nbsp; Caffeine and Sodium Benzoate |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Caffeine and Sodium Benzoate
| Product NDC: | 0517-2502 |
| Labeler Name: | American Regent, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | |
| Marketing Category: | UNAPPROVED DRUG OTHER |
| Start Marketing Date: | 19930201 |
Package Information of Caffeine and Sodium Benzoate
| Package NDC: | 0517-2502-10 |
| Package Description: | 10 VIAL, SINGLE-DOSE in 1 BOX (0517-2502-10) > 2 mL in 1 VIAL, SINGLE-DOSE |
NDC Information of Caffeine and Sodium Benzoate
| NDC Code | 0517-2502-10 |
| Proprietary Name | Caffeine and Sodium Benzoate |
| Package Description | 10 VIAL, SINGLE-DOSE in 1 BOX (0517-2502-10) > 2 mL in 1 VIAL, SINGLE-DOSE |
| Product NDC | 0517-2502 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Caffeine and Sodium Benzoate |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 19930201 |
| Marketing Category Name | UNAPPROVED DRUG OTHER |
| Labeler Name | American Regent, Inc. |
| Substance Name | CAFFEINE |
| Strength Number | 125 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Methylxanthine [EPC],Xanthines [Chemical/Ingredient] |
